Retiran miles de pastillas para la tiroides por un posible exceso de hormona que puede provocar graves problemas cardíacos

FDA recalls Vitruvias thyroid tablets after testing finds potential ‘superpotency’; here’s who faces greater…

Vitruvias Therapeutics has announced a voluntary recall of its thyroid tablets after tests indicated the potential for superpotency, which could lead to serious health risks. The recall specifically involves Lot Number…